← All trials
NCT00111150
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2005
- Primary completion
- —
- Completion date
- Mar 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 1200
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- Gilead SciencesCollaborator
- Botswana Ministry of HealthCollaborator
- Centers for Disease Control and Prevention (CDC)Study chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.